Eversept Partners
GOSS icon

Eversept Partners’s Gossamer Bio GOSS Stock Holding History

Eversept Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,565
Closed -$2.43M – 110
2025
Q3 		$2.43M Sell
11,565
-9,632
-45% -$1.7M 0.17% 63
2025
Q2 		$2.09M Sell
21,197
-27,514
-56% -$2.4M 0.19% 52
2025
Q1 		$4.29M Sell
48,711
-13,520
-22% -$1.25M 0.44% 35
2024
Q4 		$4.5M Hold
62,231
– – 0.4% 44
2024
Q3 		$4.91M Sell
62,231
-6,321
-9% -$486K 0.34% 39
2024
Q2 		$4.94M Sell
68,552
-6,379
-9% -$382K 0.34% 43
2024
Q1 		$7.07M Sell
74,931
-5,478
-7% -$482K 0.47% 41
2023
Q4 		$5.87M Buy
80,409
+25,061
+45% +$1.48M 0.52% 35
2023
Q3 		$3.69M Buy
55,348
+45,977
+491% +$4.24M 0.31% 51
2023
Q2 		$900K Sell
9,371
-7,530
-45% -$750K 0.08% 64
2023
Q1 		$1.7M Buy
16,901
+14,973
+777% +$2.29M 0.12% 53
2022
Q4 		$335K Sell
1,928
-4,927
-72% -$3.25M 0.03% 62
2022
Q3 		$6.57M Buy
6,855
+1,001
+17% +$994K 0.57% 35
2022
Q2 		$3.92M Buy
5,854
+1,170
+25% +$725K 0.28% 51
2022
Q1 		$3.25M Buy
4,684
+4,185
+839% +$3.23M 0.25% 53
2021
Q4 		$451K Sell
499
-1,375
-73% -$1.31M 0.03% 100
2021
Q3 		$1.88M Buy
+1,874
New +$1.38M 0.13% 79

Other funds holding GOSS

NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Octagon Capital Advisors
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Samsara BioCapital
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
HHLR Advisors
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Eversept Partners's GOSS Position: Q4 2025 in Review

Eversept Partners sold out of Gossamer Bio (GOSS) in Q4 2025, closing a stake of 11,565 shares — an estimated $2.43M sold.

Eversept Partners first reported a position in GOSS in Q3 2021 and held it in 17 quarters. The position peaked at $7.07M in Q1 2024. 192 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

  • Eversept Partners reported no remaining Gossamer Bio position as of Q4 2025 after selling out during the quarter.
  • Eversept Partners sold 11,565 Gossamer Bio shares in Q4 2025, an estimated $2.43M.
  • Eversept Partners first reported a position in Gossamer Bio in Q3 2021 and held it in 17 quarters.
  • Eversept Partners's Gossamer Bio position peaked at $7.07M in Q1 2024.
  • 192 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on Eversept Partners's 13F filing for Q4 2025, filed 17 Feb 2026.